Previously, we generated an MDA-MB-231 breast cancer cell line carrying a tetracycline-inducible small hairpin RNA (shRNA) construct to knockdown endogenous TDRD3 levels [14]. The gene discussed is TDRD3; the disease is breast carcinoma.